Lawrence Jerome Grylack M.D.

• 
  www.imagingeconomics.com/press_release.asp?id=10075782 - [Cached Version]
  Published on: 4/11/2007    Last Visited: 4/17/2007  

  -- Lawrence Grylack, M.D., is a Principal Consultant at PAREXEL
  
  Consulting.Prior to joining PAREXEL Consulting, Dr. Grylack served as
  ...
  Grylack taught in the Department of Pediatrics at the Georgetown
  
  University School of Medicine, and conducted clinical research.Dr.
  
  Grylack is Board Certified in pediatrics and neonatal-perinatal

• 
  www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/w - [Cached Version]
  Published on: 4/11/2007    Last Visited: 4/13/2007  

  -- Lawrence Grylack, M.D., is a Principal Consultant at PAREXEL Consulting.Prior to joining PAREXEL Consulting, Dr. Grylack served as
  ...
  Grylack taught in the Department of Pediatrics at the Georgetown University School of Medicine, and conducted clinical research.Dr. Grylack is Board Certified in pediatrics and neonatal-perinatal medicine and holds an M.D. from Tufts University School of Medicine, and a Bachelor's degree from Brandeis University.He was granted fellowships in neonatology from Washington Hospital Center and

• 
  www.stockhouse.com/news/news.asp?tick=PRXL&newsid=50402 - [Cached Version]
  Published on: 4/11/2007    Last Visited: 4/11/2007  

  -- Lawrence Grylack, M.D., is a Principal Consultant at PAREXELConsulting.Prior to joining PAREXEL Consulting, Dr. Grylack served as
  ...
  Grylack taught in the Department of Pediatrics at the GeorgetownUniversity School of Medicine, and conducted clinical research.Dr.Grylack is Board Certified in pediatrics and neonatal-perinatalmedicine and holds an M.D. from Tufts University School of Medicine,and a Bachelor's degree from Brandeis University.He was grantedfellowships in neonatology from Washington Hospital Center and

• 
  www.contractpharma.com/news/2007/04/11/executive_moves% - [Cached Version]
  Published on: 4/11/2007    Last Visited: 4/12/2007  

  Lawrence Grylack, M.D., was appointed principal consultant.Prior to joining the company, Dr. Grylack served as medical officer in the Division of Pediatric Drug Development in the Office of Counterterrorism and Pediatric Drug Development, and the Division of Pulmonary and Allergy Drug Products at the FDA Center for Drug Evaluation and Research (CDER).In this role, he handled reviews of adverse event reports, INDs and NDAs, and performed consultations for other CDER Divisions and other FDA Centers.

• 
  Medical Informatics Consulting - [Cached Version]
  Published on: 4/11/2007    Last Visited: 3/11/2009  

  Lawrence Grylack, M.D., is a Principal Consultant at PAREXEL Consulting. Prior to joining PAREXEL Consulting, Dr. Grylack served as Medical Officer in the Division of Pediatric Drug Development in the Office of Counterterrorism and Pediatric Drug Development, and the Division of Pulmonary and Allergy Drug Products at the FDA Center for Drug Evaluation and Research (CDER). In this role, he handled reviews of adverse event reports, investigational new drugs (INDs) and new drug applications (NDAs), and performed consultations for other CDER Divisions and other FDA Centers. His 40 years of medical experience include positions as a neonatologist at Columbia Hospital for Women, Georgetown University Hospital, and Fairfax Hospital. Previously, Dr. Grylack taught in the Department of Pediatrics at the Georgetown University School of Medicine, and conducted clinical research. Dr. Grylack is Board Certified in pediatrics and neonatal-perinatal medicine and holds an M.D. from Tufts University School of Medicine, and a Bachelor's degree from Brandeis University. He was granted fellowships in neonatology from Washington Hospital Center and Georgetown University.

• 
  PAREXEL Consulting - [Cached Version]
  Published on: 10/9/2006    Last Visited: 7/25/2008  

  Pediatric Drug Development: Focus on US Regulatory Issues by Dr Lawrence Grylack, MD, Principal Consultant, PAREXEL Consulting

• 
  PAREXEL Consulting | News & Events | Articles and... - [Cached Version]
  Last Visited: 2/7/2009  

  Dr. Lawrence Grylack, MD, Principal Consultant, PAREXEL Consulting, authored Pediatric Drug Development: Focus on US Regulatory Issues in the March issue of RAPS Focus.

• 
  PAREXEL Consulting | News & Events | Press Releases - [Cached Version]
  Published on: 4/11/2007    Last Visited: 2/7/2009  

  Lawrence Grylack, M.D., is a Principal Consultant at PAREXEL Consulting. Prior to joining PAREXEL Consulting, Dr. Grylack served as Medical Officer in the Division of Pediatric Drug Development in the Office of Counterterrorism and Pediatric Drug Development, and the Division of Pulmonary and Allergy Drug Products at the FDA Center for Drug Evaluation and Research (CDER). In this role, he handled reviews of adverse event reports, investigational new drugs (INDs) and new drug applications (NDAs), and performed consultations for other CDER Divisions and other FDA Centers. His 40 years of medical experience include positions as a neonatologist at Columbia Hospital for Women, Georgetown University Hospital, and Fairfax Hospital. Previously, Dr. Grylack taught in the Department of Pediatrics at the Georgetown University School of Medicine, and conducted clinical research. Dr. Grylack is Board Certified in pediatrics and neonatal-perinatal medicine and holds an M.D. from Tufts University School of Medicine, and a Bachelor's degree from Brandeis University. He was granted fellowships in neonatology from Washington Hospital Center and Georgetown University.

• 
  PAREXEL Consulting | Our Experise | Expert Services - [Cached Version]
  Published on: 2/7/2009    Last Visited: 2/7/2009  

  Lawrence Grylack

• 
  PAREXEL Consulting | Our Experise | Experts - [Cached Version]
  Published on: 7/25/2008    Last Visited: 7/25/2008  

  Dr. Lawrence Grylack, Principal ConsultantPAREXEL Consulting | Our Experise | Experts
  
  PAREXEL Consulting Logo
  ...
  Lawrence Grylack, M.D., is a Principal Consultant at PAREXEL Consulting.Prior to joining PAREXEL Consulting, Dr. Grylack served as Medical Officer in the Division of Pediatric Drug Development in the Office of Counterterrorism and Pediatric Drug Development, and the Division of Pulmonary and Allergy Drug Products at the FDA Center for Drug Evaluation and Research (CDER).In this role, he handled reviews of adverse event reports, investigational new drugs (INDs) and new drug applications (NDAs), and performed consultations for other CDER Divisions and other FDA Centers.His 40 years of medical experience include positions as a neonatologist at Columbia Hospital for Women, Georgetown University Hospital, and Fairfax Hospital.Previously, Dr. Grylack taught in the Department of Pediatrics at the Georgetown University School of Medicine, and conducted clinical research.Dr. Grylack is Board Certified in pediatrics and neonatal-perinatal medicine and holds an M.D. from Tufts University School of Medicine, and a Bachelor's degree from Brandeis University.He was granted fellowships in neonatology from Washington Hospital Center and Georgetown University.

Page:  1 2